Literature DB >> 21678496

XIAP-associated factor 1 (XAF1), a novel target of p53, enhances p53-mediated apoptosis via post-translational modification.

Bing Zou1, Chor S Chim, Roberta Pang, Hui Zeng, Yun Dai, Rongxin Zhang, Colin S C Lam, Victoria P Y Tan, Ivan F N Hung, Hui Y Lan, Benjamin C Y Wong.   

Abstract

The role of X chromosome-linked inhibitor of apoptosis protein (XIAP)-associated factor 1 (XAF1) in mediating apoptosis has been reported but the underlying mechanism remains unclear. The present study was designed to examine the putative interaction between XAF1 and p53 and the functional importance of this interaction in regulation of apoptosis in human gastric and colon cancer cells. We first identified XAF1 as a novel target gene of p53 by the chromatin immunoprecipitation (CHIP) assay and demonstrated that wild-type p53, but not mutant p53, down-regulated XAF1 at both mRNA and protein levels, which acted mostly under the condition of high expression of XAF1 and was associated with the physical interaction between p53 and the XAF1 promoter. We also found that the over-expression of XAF1 led to activation of wild-type p53 via post-translational modification in cells with or without DNA damage, which resulting in p53 nuclear accumulation and its increased transcriptional activity and enhancing p53-dependent apoptosis. These findings suggest that a potential novel feedback loop exists between XAF1 and wild-type p53.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21678496     DOI: 10.1002/mc.20807

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  19 in total

Review 1.  The DNA damage-induced cell death response: a roadmap to kill cancer cells.

Authors:  Sonja Matt; Thomas G Hofmann
Journal:  Cell Mol Life Sci       Date:  2016-01-20       Impact factor: 9.261

2.  XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313.

Authors:  Min-Goo Lee; Jikhyon Han; Seong-In Jeong; Nam-Gu Her; Jin-Hee Lee; Tae-Kyu Ha; Min-Ju Kang; Byung-Kyu Ryu; Sung-Gil Chi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

3.  Restoring PU.1 induces apoptosis and modulates viral transactivation via interferon-stimulated genes in primary effusion lymphoma.

Authors:  H Goto; R Kariya; E Kudo; Y Okuno; K Ueda; H Katano; S Okada
Journal:  Oncogene       Date:  2017-05-08       Impact factor: 9.867

4.  p53 mediated apoptosis in osteosarcoma MG-63 cells by inhibition of FANCD2 gene expression.

Authors:  Peng Xia; Yifu Sun; Changjun Zheng; Tingting Hou; Mingyang Kang; Xiaoyu Yang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

5.  NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53.

Authors:  Qingqing Cai; Meifeng Tu; Zijun Y Xu-Monette; Ruifang Sun; Ganiraju C Manyam; Xiaolu Xu; Alexander Tzankov; Eric D Hsi; Michael B Møller; L Jeffrey Medeiros; Chi Young Ok; Ken H Young
Journal:  Mod Pathol       Date:  2017-03-10       Impact factor: 7.842

6.  A novel splice variant of XIAP-associated factor 1 (XAF1) is expressed in peripheral blood containing gastric cancer-derived circulating tumor cells.

Authors:  Keiichi Hatakeyama; Yushi Yamakawa; Yorikane Fukuda; Keiichi Ohshima; Kanako Wakabayashi-Nakao; Naoki Sakura; Yutaka Tanizawa; Yusuke Kinugasa; Ken Yamaguchi; Masanori Terashima; Tohru Mochizuki
Journal:  Gastric Cancer       Date:  2014-09-13       Impact factor: 7.370

7.  ZNF313 is a novel cell cycle activator with an E3 ligase activity inhibiting cellular senescence by destabilizing p21(WAF1.).

Authors:  J Han; Y-L Kim; K-W Lee; N-G Her; T-K Ha; S Yoon; S-I Jeong; J-H Lee; M-J Kang; M-G Lee; B-K Ryu; J-H Baik; S-G Chi
Journal:  Cell Death Differ       Date:  2013-05-03       Impact factor: 15.828

8.  WZY-321 triggers glioma cell apoptosis via XAF1 up-regulation caused by MTM-mediated miR-873 down-regulation.

Authors:  Guan Sun; Wei Yuan; Weiye Zhu; Jian Chen
Journal:  J Cancer       Date:  2022-04-18       Impact factor: 4.478

Review 9.  The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme.

Authors:  Amin Daei Sorkhabi; Aila Sarkesh; Hossein Saeedi; Faroogh Marofi; Mahnaz Ghaebi; Nicola Silvestris; Behzad Baradaran; Oronzo Brunetti
Journal:  Front Oncol       Date:  2022-04-19       Impact factor: 5.738

10.  p53 and Ceramide as Collaborators in the Stress Response.

Authors:  Rouba Hage-Sleiman; Maria O Esmerian; Hadile Kobeissy; Ghassan Dbaibo
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.